Servier Executive: ‘We Are Not Looking for Blockbusters, We’re Looking for Innovative Science’
Servier completed its acquisition of Day One Biopharmaceuticals and its buyout of Edgewise Therapeutics’ neuromuscular…
Servier completed its acquisition of Day One Biopharmaceuticals and its buyout of Edgewise Therapeutics’ neuromuscular business is expected to close later this year. At the BIO International Convention, Servier’s top business development executive explained the rationale for these deals and how they fit the company’s overall strategy. The post Servier Executive: ‘We Are Not Looking…
Zelis has introduced an AI solution to help health insurers streamline the No Surprises Act’s Independent Dispute Resolution process. The post Zelis Unveils Solution to Tackle Payer IDR Challenges appeared first on MedCity News.
This brief provides an overview of the relationship between racial discrimination and health and highlights research examining mechanisms underlying health outcomes linked to experiences of racial discrimination, including biological changes, chronic stress, mental health, substance use, pregnancy-related outcomes, and sleep.
In this month’s pivot podcast, I speak to the chief medical officer of San Francisco-based Vynca, an innovative company in the world of palliative care that is providing serious disease management at home. The post MedCity Pivot Podcast: The Evolution of At-Home Care appeared first on MedCity News.
This requires more than deploying the right technology. It demands a reevaluation of how these systems fit into the healthcare environment and how to bring patients and staff along. The post Hospitals Have Always Had Eyes — AI is Giving Them a Brain appeared first on MedCity News.
We should ask a more nuanced question than “does AI work in drug discovery.” Rather, we should ask which approaches are about to be proven, and which are about to be exposed, because the field is several bets, and they are not equally sound. The post The AI Drug Discovery Race Is Heating Up, Not…
To meet the modern patient where they are, we must pivot away from managing chronic diseases to preventing them entirely, replacing a legacy system of triage with a new model that emphasizes proactive, personalized prevention. The post From Management to Personalized Prevention: The Phase Shift in Chronic Disease appeared first on MedCity News.
More than 40 million Americans live with migraine and other headache disorders. They include children trying to stay in school, workers trying to remain employed, parents caring for their families, veterans and first responders living with post-traumatic headache, and more. The post Headache Disorders Have Been Part of the American Story for 250 Years appeared…
[Sponsored] Zelis CEO Amanda Eisel discussed how AI can create value when it is applied to measurable outcomes: simplifying claims workflows, reducing administrative burden, strengthening payment integrity, improving the payments experience, and empowering members to navigate their healthcare financial journey with confidence. The post How Payers Can Use AI to Improve the Healthcare Financial Experience…
It’s tick season, possibly the worst in a decade. More and more Americans are being exposed to these parasites as climate change expands the range where they can survive. That means more people are also exposed to the bevy of health conditions they can cause, such as Rocky Mountain spotted fever, the alpha-gal-triggered red meat…